-
Coronary artery calcium scores predict heart attack risk: 5 things to know
Coronary artery calcium scores can accurately assess cardiovascular risk for both men and women, according to a study presented at the American Heart Association's annual Scientific Sessions Nov. 18. -
Number of cardiologists jumping to hospital practice doubles: Study
Between 2008 and 2019, the share of cardiologists practicing in a hospital, as opposed to an independent practice, increased from 26% to 63%, according to a study published Nov. 15 in the Journal of the American College of Cardiology. -
GLP-1 reduced heart failure risk by 46%: 8 study takeaways
The GLP-1 tirzepatide, the active ingredient in Eli Lilly's Mounjaro, was found to reduce the risk of heart failure by 46% among individuals with obesity, according to a study published Nov. 16 in The New England Journal of Medicine and presented at the American Heart Association's annual Scientific Sessions. -
Mass General Brigham names Heart and Vascular Institute leader
Somerville, Mass.-based Mass General Brigham has appointed Patrick Ellinor, MD, PhD, as the inaugural executive director of the system's Heart and Vascular Institute. -
Artificial heart saves 4th patient
Surgeons at Cincinnati-based The Christ Hospital performed a successful human implantation of the BiVACOR Total Artificial Heart, marking the fourth hospital in the U.S. to complete the procedure as part of the FDA's early feasibility study. -
FDA warns of arterial bypass device safety concerns: 5 things to know
The FDA has warned providers of safety concerns and supply issues for Getinge/Maquet's VasoView HemoPro Endoscopic Vessel Harvesting Systems. -
Donations continue for $265M heart institute
Naples, Fla.-based NCH Healthcare System continues to receive donations for the system's $265 million heart institute, expected to open in 2027. -
Hospitals with highest, lowest readmission rates for coronary bypass
Tyler, Texas-based Christus Mother Frances Hospital had the lowest unplanned readmission rate for coronary artery bypass graft surgery in the U.S. between July 1, 2020, and July 30, 2023, according to CMS data released Oct. 30. -
FDA guidelines overlooked for common blood clot device: 5 notes
Designed to temporarily prevent blood clots from traveling to the lungs, approximately 85% of inferior vena cava filters inserted over an eight-year period were not removed, according to a study published Nov. 6 in JAMA. -
180% increase in obesity-related heart disease deaths: 8 notes
Between 1999 and 2020, obesity-related heart disease deaths in the U.S. increased by 180%, according to a preliminary study to be presented at the American Heart Association's annual Scientific Sessions, set for Nov. 16-18. -
New stroke guidelines a 'huge step forward,' Northwestern cardiologist says
The American Heart Association and American Stroke Association recently published updated guidelines for the prevention of stroke. Some of the key updates include the utilization of GLP-1 medications and an emphasis on prevention of stroke in women. -
GLP-1, SGLT2s lower mortality risk by 74% in stroke survivors: Study
Stroke survivors who took GLP-1 or SGLT2 medications had a 74% lower risk of death, according to a preliminary study being presented at the American Heart Association's annual Scientific Sessions, set for Nov. 16-18. -
Hypertension in the US: 5 notes
Nearly half of all adults in the U.S. had hypertension between August 2021 and 2023, though men were less likely to be aware of their status. -
Top hospitals for stroke care: Healthgrades
Healthgrades published its 2025 Specialty Excellence Awards recipients Oct. 22. Of those, 99 hospitals were recognized for delivering superior clinical outcomes in the care and treatment of stroke. -
'A catalyst for change': Why Walmart heiress partnered with Cleveland Clinic, Mercy on cardiac care
Cleveland Clinic, Chesterfield, Mo.-based Mercy and Bentonville, Ark.-based nonprofit organizations the Alice L. Walton Foundation and the Heartland Whole Health Institute have partnered to invest $700 million over 30 years to address the "$950 million lost annually" as patients leave Northwest Arkansas for specialty care, according to a Sept. 24 news release shared by Cleveland Clinic. -
The cancer-cardiology connection: 6 takeaways
The annual Global Cardio-Oncology Summit was held in September, bringing together healthcare professionals in the context of cardiovascular disease and cancer. -
ECU Health leader named cardiology group president
Greenville, N.C.-based ECU Health's director of cardiovascular disease management services, Stacey Greenway, was appointed president of the American Association of Cardiovascular and Pulmonary Rehabilitation. -
Resorbable stent vs. balloon angioplasty safety outcomes: 5 study notes
A drug-eluting resorbable stent was found to be just as effective in treating infrapopliteal artery disease in patients at risk of limb amputation, according to a study published Oct. 25 in the New England Journal of Medicine. -
GLP-1 saved heart failure patients more than $7K in medical costs
Semaglutide treatment was found to reduce healthcare costs significantly for patients with overweight or obesity and who had either heart failure or atherosclerotic cardiovascular disease, according to studies presented Nov. 3-6 at the Obesity Society's annual Obesity Week conference and reviewed Nov. 6 in the American Journal of Managed Care. -
Immunotherapy's link to myocarditis: 3 notes
Researchers are starting to learn more about a rare but deadly side effect of immunotherapy cancer treatment, according to a study published Nov. 6 in Nature.
Page 2 of 50